was compared with placebo in a randomized double-blind study in the early postoperative period, using 50 patients recovering from major urological operations. Analgesic efficacy was individually titrated with intravenous fentanyl by means of a PCA pump (demand dose 34 gg, lockout time 5 rain). The test systems were applied 8 h before anaesthesia and were left in situ for 24 h.
Transdermal drug administration is a relatively new concept. After a gradual rise it produces a constant plasma concentration for a prolonged period. Its use has already been reported for a variety of therapeutic agents, including cardiovascular drugs, hormones and antiemetics [1, 2, 4, 7, 8, 16, 28, 30] .
The transdermal therapeutic system Fentanyl-TTS (Alza Corporation) is available in several sizes that differ in overall delivery rate. The pharmacodynamics and kinetics of fentanyl after transdermal application have already been evaluated in clinical trials for the treatment both of acute and chronic pain. The aim of the present randomized, double-blind study was to investigate the efficacy of transdermal fentanyl in the management of postoperative pain in patients recovering from major urological surgery under standardized general anaesthesia. Taking into account the known latency period of transdermal systems [3, 5, 9, 11, 14, 17, 29] , fentanyl or placebo TTS was administered 8 h prior to surgery. During postoperative recovery, patients could titrate their own pain relief using a patient-controlled analgesia system with intravenous fentanyl. It was expected that the additional consumption of intravenous fentanyl could be used as a measure of clinical efficacy.
Patients and methods
After goining Ethics Committee approval and informed written consent, 50 patients (17 women and 33 men; ages 23-75 y; ASA risk classification I-III), who were scheduled to undergo elective major urological surgery, were randomly assigned to two groups to receive fentanyl (Group 1) or a placebo transdermal system (Group 2). The TTS was applied to a hair-free area of the upper thorax 8 h before the induction of anaesthesia.
Anaesthesia was induced using intravenous thiopental 4 rag. kg i and vecuronium 0.1 mg. kg 1. Following endotracheal intubation, patients were mechanically normoventilated with 67% nitrous oxide in oxygen and isoflurane 0.5-1.2%. A single intravenous dose of fentanyl 0.1 mg was injected immediately prior to skin incision. Fentanyl injections 0.05-0.1 mg were given intraoperatively in case of clinical signs of pain (rise in blood pressure or heart rate to more than 20% of preinduction value, lacrimation or sweating), but no later than until 90 min prior to extubation. Neuromuscular blockade was maintained by repeated injection of vecuronium 1 mg as clinically needed.
As soon as the patients in the recovery room were fully orientated, they were connected to a PCA pump (Prominject, Pharmacia:
[27]), and they were encouraged to self-administer intravenous doses of fentany134 gg whenever they experienced insufficient analgesia. The pump refractory time was set to 5 min, thus limiting the hourly maximum dose to 0.4 fentanyl mg. h-2. PCA was continued until the following morning. To prevent nausea and vomiting, prophylactic droperidol i mg i. v. was administered at the beginning of PCA. Further doses of droperidol 1 mg were given as necessary.
Blood pressure, heart rate, respiratory frequency, pain intensity (using a visual analogue scale (VAS) 0-100) and side effects were documented hourly during the first 10 post-operative hours. All valid demands were noted as well as the exact time. From those data, hourly and cumulative doses were calculated and were evaluated as a function of time.
Arterial blood gas analyses were performed at the beginning of patient-controlled analgesia and at various times during the treatment period, when clinically indicated. Patients with a respiratory frequency <8/min for a period of more than 5rain, p,CO2 > 55 mm Hg or insufficient pain relief were planned to be withdrawn from the study. The TTS was removed 24 h after application and local skin site reactions were recorded 0, 1, 6, and 24 h later.
On the fourth postoperative day, patients were interviewed using a standard protocol in order to evaluate their acceptance of PCA, K. A. Lehmann et al.: Transdermal fentanyl and a retrospective verbal pain score for the treatment period was assigned from a six-point verbal rating scale (VRS, 0 no pain at all; 1 sometimes moderate; 2 always moderate; 3 sometimes severe; 4 always moderate, sometimes severe pain; and 5 discontinuation due to inefficacy) and a visual analogue scale (VAS, 0-100).
For statistical analysis, arithmetic means, standard deviations and ranges were calculated (SPSS). Subgroups were compared by means of the Student's t-test for unpaired values, the Mann-Whitney-Wilcoxon test for independent samples and the Chi-square test (level of significance: P <_ 0,05).
Results
The subgroups did not differ significantly in age, sex, weight, height, preoperative consumption of analgesics, alcohol or smoking habits, or duration of anaesthesia or PCA. Demographic and anaesthesiological data are summarized in Table 1 . The operations performed in each subgroup are listed in Table 2 . Fentanyl-TTS proved to be effective during the intraoperative period, since significantly less intravenous fentanyl was required in the active group (Table 1) .
The PCA results are summarized in Table 3 . Individual fentanyl supplementation in both groups was highly variable (Fig. 1) . Cumulative i.v. fentanyl consumption (mg, gg. kg-1 and gg-kg-1. h-1) was significantly less in the active group. The time course of the mean cumulative PCA fentanyl dosage is shown in Fig. 2 .
Actual but not retrospective pain scores differed significantly between the subgroups. As can be seen from Fig. 3 , the VAS scores were significantly lower between the third and ninth hours after starting PCA. Retrospective pain scores are summarized in Table 3 .
There was no significant difference in haemodynamic parameters between the subgroups. Mean respiratory frequency was lower in the active group (Fig. 4) . The difference, although clinically irrelevant, was significant during the 8 to 10h after starting PCA. Respiratory depression requiring treatment did not occur in any patient.
Side effects did not differ significantly between the subgroups (Table 4) . No comment can be made about urinary retention, since all the patients had a urinary catheter. Sedation, as frequently reported, was generally described as pleasant. All patients were easily arousable. Taking into account that a prophylactic antiemetic had been given, postoperative nausea mostly occurred in a mild form, and was readily controlled with droperidol.
Discussion
Inadequate pain relief is a frequent complaint of postoperative patients. Amongst the possible reasons for this serious failure of modern anaesthesiology, the most common are underprescription of potent narcotics by physicians, underdosage of vaguely prescribed analgesics by the nursing staff, and insufficient control of the therapeutic outcome, which is essential for individual titration of analgesic needs.
Patient-controlled analgesia (PCA) has proven to be a highly effective and well accepted method of acute pain
